P.102 Long-term adefovir dipivoxil treatment induces regression of liver fibrosis in patients with HBeAg-negative chronic hepatitis B: results after 5 years of therapy
S. Hadziyannis, Steven L. Chuck(Gilead Sciences (United States)), Patrick Marcellin(Inserm), Elsa Mondou, Jianmin Ma, Z. Goodman, Mario Rizzetto(University of Turin), Sarah Arterburn(Gilead Sciences (United States)), Ting‐Yu Chang, N.C. Tassopoulos, G. Kitis(G. Papanikolaou General Hospital), Seng Gee Lim(National University of Singapore), Jenny Heathcote(University of Toronto), Katyna Borroto–Esoda(Gilead Sciences (United States))
Cited by 59
Related Papers
International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis
|Journal of Hepatology|1999|2.9k
Nonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
|Hepatology|2003|2.7k
Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
|New England Journal of Medicine|2013|1.8k
Peginterferon Alfa-2a Alone, Lamivudine Alone, and the Two in Combination in Patients with HBeAg-Negative Chronic Hepatitis B
|New England Journal of Medicine|2004|1.1k
Tenofovir DF, Emtricitabine, and Efavirenz vs. Zidovudine, Lamivudine, and Efavirenz for HIV
|New England Journal of Medicine|2006|886